Tech Company Financing Transactions
Roslin Technologies Funding Round
Novo Holdings, Alchimia Investments and Esco Lifesciences participated in a $12.6 million Series A funding round for Roslin Technologies. The round closed on 11/7/2022.
Transaction Overview
Company Name
Announced On
11/7/2022
Transaction Type
Venture Equity
Amount
$12,600,000
Round
Series A
Investors
Novo Holdings (Lead Investor) (Nis Bak)
Proceeds Purpose
The company intends to use the funds to accelerate growth, expand its cell line portfolio, further develop the protocols for scaling up of its cells, and invest in its insect venture.
Company Information
Company Status
Private & Independent
Industry
AgTech
Mailing Address
Roslin Innovation Centre, Easter Bush Campus University of E
Midlothian, EH25 9RG
UK
Midlothian, EH25 9RG
UK
Phone
Website
Email Address
Overview
Our mission is to advance disruptive biotechnologies to improve protein production. The world is facing a protein deficit - we are over-exploiting the natural environment and need to find alternative ways to produce proteins. Great progress is being made, but we still need to innovate faster. At Roslin Tech, we apply new biotechnologies to accelerate the transition to a more sustainable food system. We want to live in a world where everyone has access to affordable, nutritious, and responsibly produced protein.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ernst Orsouw
Chief Financial Officer
George Roy
Chief Operating Officer
John Clinkenbeard
Browse more venture capital transactions:
Prev: 11/7/2022: Circle Labs venture capital transaction
Next: 11/8/2022: Biotic venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs